Dr. Chris Jeffery, founder and CEO of Convergence Medical, discusses the V01, the world's first arthroscopic surgical robot.
In a recent interview with SmartTRAK, Dr. Chris Jeffery, the founder and CEO of Convergence Medical, discussed the V01, the world’s first dedicated arthroscopic surgical robot. In the interview, Dr. Jeffery shared insights into the V01’s novel design, business model, and technological advancements that position it as the next evolution in arthroscopic innovation. The V01 received FDA breakthrough designation in 2023 and is on track for FDA clearance and a US launch in late 2025.
Click on the following video to watch the interview (59:11 min). A complete transcript of the interview is available here. For more details, interview topics by timecode are provided below.
Interview Topics By Timecode:
- 00:50 Dr Jeffery’s background.
- 10:00 V01 overview.
- 20:25 Performing a repair with the V01.
- 26:50 V01 cost.
- 36:10 Surgeon feedback.
- 40:10 Importance of an arthroscopy-specific robot.
- 42:40 Novel design of the V01.
- 44:45 Commercial path.
Click the button below to download a complete transcript of SmartTRAK's interview with Dr. Chris Jeffrey, CEO of Convergence Medical Sciences, conducted by Andy Knapik, Senior Analyst, Soft Tissue Fixation and Arthroscopic Enabling Technologies.